Literature DB >> 29621365

Association of Hypovitaminosis D With Increased Risk of Uveitis in a Large Health Care Claims Database.

Lucia Sobrin1, Lynn K Stanwyck1, Wei Pan2, Rebecca A Hubbard3, John H Kempen1,4, Brian L VanderBeek2.   

Abstract

Importance: Understanding the role of vitamin D-which regulates inflammatory responses-in noninfectious uveitis (an inflammatory disease) may provide insight into treatment and prevention of this disease. Objective: To investigate whether there is an association between hypovitaminosis D and incident noninfectious uveitis. Design, Setting, and Participants: In a retrospective case-control study, data from a health care claims database containing deidentified medical claims from a large private insurer were used to identify 558 adults enrolled from January 1, 2000, to December 31, 2016, who received a diagnosis of noninfectious uveitis from an eye care clinician (with receipt of a confirmatory diagnosis within 120 days of the initial diagnosis) and who had a vitamin D level measured within 1 year before the first diagnosis. Exclusion criteria included having systemic disease or receiving medication known to lower vitamin D levels, having undergone intraocular surgery, and having infectious uveitis. Each case patient was matched with 5 controls on the basis of age, sex, race/ethnicity, and index date (2790 controls). The controls had vitamin D level determined either within 1 year before or within 6 months after receiving an eye examination with normal findings. Multiple logistic regression models were used to examine the association between hypovitaminosis D and noninfectious uveitis. Main Outcomes and Measures: The primary, prespecified analysis assessed the association of noninfectious uveitis with hypovitaminosis D (vitamin D level ≤20 ng/mL).
Results: The 558 cases and 2790 controls were matched on age, and each group had a mean (SD) age of 58.9 (14.7) years. Among the cohort of 3348 patients, 2526 (75.4%) were female, and the racial/ethnic distribution in the matched samples was 2022 (60.4%) white, 552 (16.5%) black, 402 (12.0%) Hispanic, 162 (4.8%) Asian, and 210 (6.3%) unknown. Patients with normal vitamin D levels had 21% lower odds of having noninfectious uveitis than patients with low vitamin D levels (odds ratio [OR], 0.79; 95% CI, 0.62-0.99; P = .04). In a race-stratified analysis, an association between vitamin D and uveitis was found in black patients (OR, 0.49; 95% CI, 0.30-0.80; P = .004) and was qualitatively similar but nonsignificant in white patients (OR, 0.87; 95% CI, 0.62-1.21; P = .40) and Hispanic patients (OR, 0.60; 95% CI, 0.33-1.10; P = .10). Conclusions and Relevance: This and other reports have found an association between hypovitaminosis D and noninfectious uveitis. However, these studies cannot establish a causal relationship. Prospective studies are warranted to evaluate whether hypovitaminosis D causes increased risk of uveitis and the role of vitamin D supplementation in prevention and treatment of uveitis.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29621365      PMCID: PMC6050585          DOI: 10.1001/jamaophthalmol.2018.0642

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  14 in total

1.  Association of Low Vitamin D Levels With Noninfectious Anterior Uveitis.

Authors:  Lindsay A Grotting; Samaneh Davoudi; Deanna Palenzuela; George N Papaliodis; Lucia Sobrin
Journal:  JAMA Ophthalmol       Date:  2017-02-01       Impact factor: 7.389

2.  Uveitis in adult patients with rheumatic inflammatory autoimmune diseases at a tertiary-care hospital in Mexico City.

Authors:  Francisco Javier Jiménez-Balderas; Gema Fernandez-Arrieta; Adolfo Camargo-Coronel; Miguel Ángel Ake-Uc; Miguel Angel Vazquez-Zaragoza; Abraham Zonana-Nacach; Luis Roberto Sánchez-González; Rita Rios; Francisco Martinez-Castro
Journal:  J Rheumatol       Date:  2010-12-01       Impact factor: 4.666

Review 3.  Vitamin D: its role and uses in immunology.

Authors:  H F Deluca; M T Cantorna
Journal:  FASEB J       Date:  2001-12       Impact factor: 5.191

4.  Expression of 1,25-dihydroxyvitamin D(3) receptor in the immune system.

Authors:  C M Veldman; M T Cantorna; H F DeLuca
Journal:  Arch Biochem Biophys       Date:  2000-02-15       Impact factor: 4.013

5.  Uveitis is not just an ophthalmologists' concern.

Authors:  Muhammad Ishaq; Jibran Sualeh Muhammad; Khalid Mahmood
Journal:  J Pak Med Assoc       Date:  2012-02       Impact factor: 0.781

6.  Calcitriol suppresses antiretinal autoimmunity through inhibitory effects on the Th17 effector response.

Authors:  Jun Tang; Ru Zhou; Dror Luger; Wei Zhu; Phyllis B Silver; Rafael S Grajewski; Shao-Bo Su; Chi-Chao Chan; Luciano Adorini; Rachel R Caspi
Journal:  J Immunol       Date:  2009-04-15       Impact factor: 5.422

7.  Basic and clinical immunology in uveitis.

Authors:  R B Nussenblatt
Journal:  Jpn J Ophthalmol       Date:  1987       Impact factor: 2.447

8.  The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know.

Authors:  A Catharine Ross; JoAnn E Manson; Steven A Abrams; John F Aloia; Patsy M Brannon; Steven K Clinton; Ramon A Durazo-Arvizu; J Christopher Gallagher; Richard L Gallo; Glenville Jones; Christopher S Kovacs; Susan T Mayne; Clifford J Rosen; Sue A Shapses
Journal:  J Clin Endocrinol Metab       Date:  2010-11-29       Impact factor: 5.958

9.  Decreased 1,25-Dihydroxyvitamin D3 level is involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.

Authors:  Xianglong Yi; Peizeng Yang; Min Sun; Yan Yang; Fuzhen Li
Journal:  Mol Vis       Date:  2011-03-09       Impact factor: 2.367

10.  The role of Vitamin D in immuno-inflammatory responses in Ankylosing Spondylitis patients with and without Acute Anterior Uveitis.

Authors:  T C Mitulescu; C Stavaru; L M Voinea; L M Banica; C Matache; D Predeteanu
Journal:  J Med Life       Date:  2016 Jan-Mar
View more
  7 in total

1.  Risk of Noninfectious Uveitis with Female Hormonal Therapy in a Large Healthcare Claims Database.

Authors:  Lucia Sobrin; Yinxi Yu; Gayatri Susarla; Weilin Chan; Tian Xia; John H Kempen; Rebecca A Hubbard; Brian L VanderBeek
Journal:  Ophthalmology       Date:  2020-04-27       Impact factor: 12.079

Review 2.  Vitamin D, the Vitamin D Receptor, Calcitriol Analogues and Their Link with Ocular Diseases.

Authors:  Miłosz Caban; Urszula Lewandowska
Journal:  Nutrients       Date:  2022-06-05       Impact factor: 6.706

Review 3.  Vitamin D and Ocular Diseases: A Systematic Review.

Authors:  Hei-Nga Chan; Xiu-Juan Zhang; Xiang-Tian Ling; Christine Huyen-Trang Bui; Yu-Meng Wang; Patrick Ip; Wai-Kit Chu; Li-Jia Chen; Clement C Tham; Jason C Yam; Chi-Pui Pang
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

4.  Angiotensin Converting Enzyme-Inhibitors and Incidence of Non-infectious Uveitis in a Large Healthcare Claims Database.

Authors:  Lucia Sobrin; Yinxi Yu; Ashley Li; John H Kempen; Rebecca A Hubbard; Brian L VanderBeek
Journal:  Ophthalmic Epidemiol       Date:  2021-02-23       Impact factor: 1.648

5.  "Environmental risk factors associated with juvenile idiopathic arthritis associated uveitis: a systematic review of the literature".

Authors:  Sarah L N Clarke; Katie S Mageean; Henry Carlton; Gabriele Simonini; Gemma C Sharp; Caroline L Relton; Athimalaipet V Ramanan
Journal:  J Ophthalmic Inflamm Infect       Date:  2021-05-24

6.  Decreased risk of non-infectious anterior uveitis with statin therapy in a large healthcare claims database.

Authors:  Lucia Sobrin; Yinxi Yu; Samuel Han; Gayatri Susarla; John H Kempen; Rebecca A Hubbard; Brian L VanderBeek
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2021-05-29       Impact factor: 3.535

7.  Risk of Non-infectious Uveitis with Metformin Therapy in a Large Healthcare Claims Database.

Authors:  Lucia Sobrin; Yinxi Yu; Samuel Han; Gayatri Susarla; John H Kempen; Rebecca A Hubbard; Brian L VanderBeek
Journal:  Ocul Immunol Inflamm       Date:  2021-03-08       Impact factor: 3.728

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.